Loading...
Statin therapy and clinical outcomes in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
Gillani, I Muneeb, Ullah Postoev, A Sharma, A Mohammed, Abdul Chaudhary, S Gunaratne, H Allahwala, D
Gillani, I
Muneeb, Ullah
Postoev, A
Sharma, A
Mohammed, Abdul
Chaudhary, S
Gunaratne, H
Allahwala, D
Abstract
Beyond their lipid-lowering effects, statins exert pleiotropic properties, including anti-inflammatory, antioxidant, and antifibrotic actions, which may confer therapeutic benefits in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). This systematic review and meta-analysis aimed to evaluate the impact of statin therapy on clinical outcomes in adults with MASLD. A comprehensive literature search was conducted across PubMed, Embase, Cochrane CENTRAL, Web of Science, and Scopus from inception through January 10, 2026. Observational studies and randomized controlled trials comparing statin therapy with placebo or no treatment in adults with MASLD were eligible for inclusion. Eight observational studies met the inclusion criteria and were included in the quantitative synthesis. The primary outcomes were hepatocellular carcinoma incidence, all-cause mortality, and liver-related mortality. Statin use was associated with a significantly lower risk of hepatocellular carcinoma (pooled risk ratio (RR) 0.56, 95% CI 0.45-0.71), all-cause mortality (pooled RR 0.81, 95% CI 0.72-0.91), and liver-related mortality (pooled RR 0.54, 95% CI 0.37-0.79). Moderate to substantial heterogeneity was observed across studies. These findings suggest that statin therapy may confer meaningful hepatic and survival benefits in patients with MASLD, supporting their proactive use, particularly given their concomitant cardiovascular advantages. Nonetheless, the observational nature of the included studies underscores the need for large-scale randomized controlled trials to establish causality and define optimal treatment strategies.
MIDER Authors
Affiliations
Al Nahyan Medical and Dental College; Rashid Latif Medical College; Carribbean Medical University; Kathmandu Medical College; University Hospitals of Derby and Burton NHS Foundation Trust; Sitapur Hospital; University of Colombo;
Date
2026-02-23
Type
Article
Collections
Files
Loading...
(12) Cureus.pdf
Adobe PDF, 1.34 MB
Citation
Gillani I, Muneeb Ullah M, Postoev A, Sharma A, Mohammed Abdul RH, Chaudhary S, Gunaratne H, Allahwala D. Statin Therapy and Clinical Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis. Cureus. 2026 Feb 23;18(2):e104139. doi: 10.7759/cureus.104139.
Journal / Source Title
PMID
Publisher
Publisher’s URL
Publisher’s statement
Gillani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0.,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.